Fredun Pharmaceuticals Limited (BOM:539730)

Fredun Pharmaceuticals Revenue

Fredun Pharmaceuticals had revenue of 1.03B INR in the quarter ending December 31, 2024, with 18.03% growth. This brings the company's revenue in the last twelve months to 4.06B, down -5.16% year-over-year. In the fiscal year ending March 31, 2024, Fredun Pharmaceuticals had annual revenue of 3.48B with 26.75% growth.

• Revenue (ttm): 4.06B
• Revenue Growth: -5.16%
• P/S Ratio: 0.82
• Revenue / Employee: 15.86M
• Employees: 256
• Market Cap: 3.34B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	3.48B	734.81M	26.75%
Mar 31, 2023	2.75B	502.16M	22.37%
Mar 31, 2022	2.24B	906.43M	67.74%
Mar 31, 2021	1.34B	211.22M	18.74%
Mar 31, 2020	1.13B	165.47M	17.21%